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Abstract
Background:  C.35delG/GJB2 mutation is the most frequent genetic cause of deafness in
Caucasians. Another frequent mutation in some Caucasian populations is del(GJB6-D13S1830).
Both GJB2 and GJB6 genes belong to the same DFNB1 locus and when the two mutations are found
in combination in a hearing-impaired person, a digenic pattern of inheritance is suggested.
Methods: We examined 63 Croatian subjects (25 familial and 38 sporadic cases) with prelingual
non-syndromic hearing impairment by polymerase chain reaction for the presence of the c.35delG/
GJB2 and the del(GJB6-D13S1830) mutations.
Results: Of the 63 unrelated hearing-impaired subjects, the mutation c.35delG/GJB2 was found in
21 subjects (33.3%). In 5 of them the mutation was found in the heterozygous state, all of them
being compound heterozygotes, as sequencing revealed a second mutation within the coding region
of the gene in 3 subjects, and a splice site mutation in 2 subjects. The del(GJB6-D13S1830) mutation
was not found in the investigated hearing-impaired Croatian subjects.
Conclusion: Our results contribute to the knowledge of geographic distribution and population
genetics of the GJB2 and GJB6 mutations in the Europeans.
Background
The identification of genes causing non-syndromic hear-
ing impairment has partially resolved the puzzle of clini-
cal and genetic heterogeneity of deafness [1]. Among
these genes the gene with the most significant impact on
the population genetics and genetic counselling is the
GJB2 gene with the mutation c.35delG that accounts for
the majority of mutations in deaf Caucasians [1-3]. Stud-
ies published so far have reported the differences in fre-
quency of the mutation in different populations, and its
variability in clinical impact on hearing impairment [4,5].
However, although the mutations in the GJB2 gene are
responsible for up to 69% of autosomal recessive non-
syndromic hearing impairment [2], a problem emerges
when patients are identified with only one GJB2 mutant
allele. Recently, in the same DFNB1 locus, a 309-kb dele-
tion implicating the GJB6 gene, del(GJB6-D13S1830), has
been identified, and was found to be very common in
non-syndromic hearing-impaired patients from Spain,
France, Israel, the United Kingdom and Brazil, suggesting
also a possible GJB2 / GJB6 digenic pattern of inheritance
of deafness [6,7]. There are no reports on frequencies of
the c.35delG/GJB2 and del(GJB6-D13S1830) mutation in
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either the hearing impaired in Croatia, or in the Slavic
populations of Central-Eastern Europe.
The aim of our study was to establish the frequencies of
c.35delG/GJB2  and del(GJB6-D13S1830) mutations in
Croatians with prelingual non-syndromic hearing impair-
ment.
Methods
Patients with hearing impairment were ascertained
through two regional otorhinolaryngology centres (Gen-
eral Hospital Pula and University Medical Centre Rijeka).
The inclusion criteria were: prelingual, non-syndromic
hearing loss of unknown aetiology. Both the patients with
familial history of deafness and sporadic cases were
included. The study group consisted of 66 patients: 29
males and 37 females, with ages ranging from 3 months
to 73 years; 28 cases had familial history of deafness, 38
were sporadic. Of the 66 subjects, 63 were unrelated.
Fifty adult patients were audiologically evaluated by pure
tone audiometry with a diagnostic audiometer in a sound-
proof room according to the International Organization
for Standardization (ISO). The conductive component of
hearing loss was excluded by tympanometry. The air con-
duction binaural mean pure tone threshold (dB hearing
loss) was recorded for 500, 1000, 2000, and 4000 Hz.
Hearing impairment was classified as mild when the aver-
age threshold was between 21 and 40 db, moderate if 41–
70 db, severe if 71–95 db, and profound if more than 95
db. In 16 children, aged from 3 months to 16 years, the
testing was performed by auditory brainstem response
[8,9].
After DNA isolation from the peripheral blood by stand-
ard procedures, all patients were molecularly evaluated
for the presence of the c.35delG mutation by allele-spe-
cific polymerase chain reaction method (PCR) [10].
Sequencing was performed in patients heterozygous for
the mutation at GENDIA – Genetic Diagnostic Network,
Antwerp, Belgium. All patients were also evaluated for the
presence of del(GJB6-D13S1830) mutation by the PCR
method described by del Castillo et al [7].
The study was approved by the institutional medical eth-
ics committee, and was performed after the informed con-
sent of the patients or their parents was obtained.
Results
Mutation analysis
Of the 63 unrelated investigated patients, the c.35delG/
GJB2  mutation was found in 21 subjects (33.3%): 12
males and 9 females. In 16 out of 63 subjects the mutation
was found in the homozygous state, in 5 in the hetero-
zygous state. In the latter cases, sequencing of the coding
exon, in search for the second mutation was performed. In
three patients the sequencing revealed, besides the
c.35delG mutation, three different second mutations
already known as pathogenic: c.235delC, p.E47X and
p.R143W respectively. In remaining two patients the
sequencing revealed a known splice site mutation which
is also already disease-associated: c.IVS1+1G>A.
Twelve homozygous and 1 heterozygous patients out of
the 21 had a positive familial history of deafness, 4
homozygous and 4 heterozygotes had no familial history
of deafness. In the group of 25 subjects with positive
familial history, 12 were homozygous for the c35delG
mutation (48%), 1 heterozygous (4%), while in the group
of 38 sporadic cases 4 were homozygous (12.5%) and 4
heterozygous (12.5%).
None of the 63 patients was found to carry the mutation
del(GJB6-D13S1830) in either the homozygous or heter-
ozygous state.
Phenotypic analysis
When considering all 66 investigated patients, the
c.35delG/GJB2 mutation was found in 24: 13 males and
11 females. In 19 out of 66 subjects the mutation was
found in the homozygous state, in 5 in the heterozygous
state. Of the 19 patients with hearing impairment due to
the c.35delG/GJB2 mutation, 16 had profound deafness,
one had severe, and two had moderate hearing loss. All
patients had sensorineural bilateral hearing loss. All but 2
patients had symmetric hearing impairment. The 3
patients – compound heterozygotes: c. [35delG] +
[235delC], c. [35delG] + p. [E47X], c. [35delG] + p.
[R143W] had also profound deafness while 2 patients
compound heterozygotes c. [35delG] + [IVS1+1G>A] had
severe and moderate deafness respectively.
Discussion
The c.35delG mutation in the GJB2 gene has been identi-
fied as the most important among genetic causes of hear-
ing impairment as it accounts for the majority of
mutations in deaf Caucasians, whether in the
homozygous state or as one of the mutations in com-
pound heterozygosity (within GJB2  or in GJB6  gene)
[4,7]. The studies have been published reporting the fre-
quency of the mutation in different populations showing
a south-to-north European gradient, where a high preva-
lence of the mutation in the populations of Southern
Europe has been explained by the founder effect
[4,5,11,12]. The share of the c.35delG involvement in
hearing impairment varies from 28 to 63% [4]. There are
only a few reports on its frequency in the populations of
Slavic origin [13,14], but no mutation frequency data
have been published on the Croatian or other Slavic Cen-
tral-Eastern European populations. The del(GJB6-BMC Ear, Nose and Throat Disorders 2005, 5:11 http://www.biomedcentral.com/1472-6815/5/11
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D13S1830) mutation has been identified as the second
most frequent mutation causing non-syndromic, prelin-
gual, autosomal recessive hearing impairment in the
European populations of Spain, France, the United King-
dom, but also in Brazilians and Jews [7]. Like the c.35delG
mutation, this deletion is also population specific as it
was established that it is very rare in Czech population,
while it is absent in the Austrian population [15,16],
showing a west-to-east European gradient and indicating
again a founder effect as it is the case of c.35delG/GJB2
mutation. There are no reports on the share of this muta-
tion in hearing impaired Slavic Central-Eastern European
populations.
Our results suggest the importance of the mutation
c.35delG in the Croatian population, the data being com-
parable to those from the neighbouring areas [4,17,18].
Besides, results such as ours suggest the introduction of
molecular genetics diagnosis of the mutation into clinical
practice with significant impact on genetic counselling.
However, although the involvement of the mutation in
the aetiology of deafness has been found in 21 out of 63
hearing-impaired Croatian subjects, a possibility should
be mentioned that some GJB2-related cases of deafness
due to two less prevalent GJB2 mutations should escape
detection in our investigation.
In our study, 16 of the 19 subjects with the c.35delG
mutation involvement had profound deafness, one had
severe and two had moderate hearing impairment. The
results are in agreement with the majority of studies on
the severity of hearing impairment related to the muta-
tion, where mainly the patients with severe to profound
hearing loss are reported, due to an important truncation
of the protein after deletion [19-21]. Patients with mild
and moderate hearing loss have been rarely reported
[22,23].
Our data on the c.35delG/GJB2 frequency in Croatia con-
tribute to the geographic distribution of the mutation in
Europe, confirming the south-to-north gradient.
On the other hand, our results on the involvement of
del(GJB6-D13S1830) mutation in the aetiology of hear-
ing impairment show that the mutation is of no epidemi-
ological and clinical importance in Croatians, the results
being in agreement with the results of the frequency of the
mutation in populations from neighbouring areas, i.e.
from Central European populations [14-16].
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